Trial intelligence / Profile preview

Daily vs Weekly Cladribine in Hairy Cell Leukemia

NCT00003746Phase 3Completed

Sponsor
Swiss Group for Clinical Cancer Research
Start
Sep 1998
Primary completion
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of cladribine in hairy cell leukemia (HCL), sponsored by Swiss Group for Clinical Cancer Research. Started Sep 1998; status: completed.

02

Drugs

cladribine
03

Conditions

hairy cell leukemia (HCL)

Beyond the preview

Go deeper on NCT00003746.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003746.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call